Mounjaro®
Starting from £179.99/mo
Start journey Learn moreFor GLP-1 weight-loss injections such as Mounjaro and Wegovy, all three licensed sites — the abdomen, outer thigh, and upper arm — deliver the medicine reliably under the skin, and no single site produces faster or greater weight loss than the others. The right site is whichever you can reach comfortably, pinch at least an inch of tissue on, and rotate consistently. These are prescription-only medicines: your prescriber and the Patient Information Leaflet in your pack are the definitive guides to technique for your specific treatment.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Reach matters more than people expect. The abdomen is the most popular starting point because both hands can manage the pen easily, you can see what you're doing, and there's usually enough subcutaneous tissue for a clean injection. Aim at least 5 cm (two finger-widths) away from the navel and away from any scar tissue or skin that feels firm. Avoid the waistband area, where clothing friction increases irritation.
The outer thigh works well for most people too. Aim for the middle third of the front-outer surface, not the inner thigh or behind the knee. If you're injecting in the upper arm, you'll generally need someone to help you, or a wall-mirror technique, because reaching the correct outer position one-handed is awkward. A question our prescribers hear most weeks is whether the arm gives a faster result, and if you want to read through which GLP-1 injection site works best for weight loss, the evidence confirms that the licensed sites are equivalent for absorption of subcutaneous medicines like tirzepatide and semaglutide.
For a broader look at how these medicines work and what to expect from treatment, the weight-loss injection overview covers the essentials clearly. If you are still deciding between treatment options, reading about which weight-loss injection suits your situation may help before you commit to a routine.
Using the same spot every week is one of the most common mistakes. Repeated injections into exactly the same patch of skin can cause lipohypertrophy, a fatty, lumpy change in the tissue that is not harmful in itself but does slow how reliably the medicine is absorbed. You wouldn't notice it immediately, but over months it can blunt the effect of your treatment.
A simple approach: think of each site as a clock face. Abdomen, move one hour clockwise each week. Left thigh one week, right thigh the next. If you add the arm, cycle through all three zones across a three-week pattern. Some people find a small note on their phone or a calendar dot keeps this automatic. The detailed guide to the best injection site sets out a rotation diagram if you want a visual reference.
Clean the skin first. An alcohol swab (left to dry for 10 seconds before injecting) reduces the risk of introducing bacteria. Fresh needles matter too: a used needle tip bends microscopically, which makes the injection more uncomfortable and increases the risk of skin trauma. The 100-pack of spare pen needles is there if you need to restock.
Mild redness, slight itching or minor bruising at the injection point is normal, particularly in the first few weeks as your skin adjusts. These reactions are listed among the common side effects in the NHS's patient information for tirzepatide. They almost always settle within a day or two and are not a reason to stop treatment.
If a reaction seems to be worsening (spreading redness, warmth, significant swelling, or discomfort that persists beyond 48 hours) contact your prescribing team. A hard lump that doesn't soften after two or three weeks is worth flagging too, as it may indicate early lipohypertrophy at that spot; the fix is simply to stop using that patch and let it recover while you rotate elsewhere.
You can read the full side-effect picture, including when to seek urgent help, on the NHS tirzepatide medicines page. For semaglutide (Wegovy), equivalent guidance sits on the NHS medicines pages for semaglutide. Reporting unexpected reactions via the MHRA Yellow Card scheme helps the regulator monitor real-world safety data for these medicines.
Technique questions like these are exactly why ongoing prescriber support is part of responsible GLP-1 treatment, not an optional extra. At nume, every repeat order is reviewed by a GPhC-registered Independent Prescriber before it's approved, not by a chatbot running through a checklist. That means if you flag an injection-site concern in your aftercare check, a real clinician reads it the same day.
If you're weighing up the cost of private treatment alongside this level of support, the weight-loss injections pricing page explains what's included and why the comparison isn't always straightforward. And if you haven't yet decided which medicine is the better fit for you, the comparison of weight-loss injections walks through the clinical evidence side by side.
When you're ready to speak to a prescriber about starting or continuing treatment, starting your free consultation takes a few minutes and is reviewed the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.